Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Mao

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Plant Biology|June 29, 2022
Overexpression of GhABF3 increases cotton(Gossypium hirsutum L.) tolerance to salt and droughtHaijun Zhang, Lili Mao, Ming Xin, et al.
Frontiers in Immunology|July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical TrialsLi Zhou, Xuan Wang, Zhihong Chi, et al.
Cancer Science|March 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal MelanomaJia Jia, Junjie Gu, Lina Gao, et al.
Melanoma Research|February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapyLi Zhou, Yue Yang, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in ChinaYang Wang, Bin Lian, Lu Si, et al.
Translational Oncology|November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapyXuan Wang, Weiran Xu, Zhihong Chi, et al.
Journal of Materials Chemistry. B|June 16, 2025
A porphyrin metal-organic framework enhances photodynamic therapy through lymphatic circulationQiuhong Ouyang, Xin Li, Yuechen He, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanomaLili Mao, Jun Guo, Lingjun Zhu, et al.
BMC Plant Biology|September 13, 2019
Genome-wide association and differential expression analysis of salt tolerance in Gossypium hirsutum L at the germination stageYanchao Yuan, Huixian Xing, Wenguan Zeng, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Plant Biology|June 29, 2022
Overexpression of GhABF3 increases cotton(Gossypium hirsutum L.) tolerance to salt and droughtHaijun Zhang, Lili Mao, Ming Xin, et al.
Frontiers in Immunology|July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical TrialsLi Zhou, Xuan Wang, Zhihong Chi, et al.
Cancer Science|March 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal MelanomaJia Jia, Junjie Gu, Lina Gao, et al.
Melanoma Research|February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapyLi Zhou, Yue Yang, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in ChinaYang Wang, Bin Lian, Lu Si, et al.
Translational Oncology|November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapyXuan Wang, Weiran Xu, Zhihong Chi, et al.
Journal of Materials Chemistry. B|June 16, 2025
A porphyrin metal-organic framework enhances photodynamic therapy through lymphatic circulationQiuhong Ouyang, Xin Li, Yuechen He, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanomaLili Mao, Jun Guo, Lingjun Zhu, et al.
BMC Plant Biology|September 13, 2019
Genome-wide association and differential expression analysis of salt tolerance in Gossypium hirsutum L at the germination stageYanchao Yuan, Huixian Xing, Wenguan Zeng, et al.
Pageof 15